Brief: Sun Pharma Advanced Research Company Gets Complete Response Letter From U.S. FDA
Feb 11 (Reuters) - Sun Pharma Advanced Research Company Ltd
SPRC.NS :
* SUN PHARMA ADVANCED RESEARCH COMPANY LTD - GETS COMPLETE
RESPONSE LETTER FROM U.S. FDA FOR NEW DRUG APPLICATION FOR
TACLANTIS
* SUN PHARMA ADVANCED RESEARCH COMPANY LTD -CO IS REVIEWING
CRL
AND INTENDS TO WORK WITH U.S. FDA
Source text for Eikon: ID:
Further company coverage: SPRC.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sun Pharma Advanced Research
See all newsAdvisory: Alert incorrectly tagged to Sun Pharma Advanced Research withdrawn
Brief: Sun Pharma Advanced Research Appoints Anil Raghavan As MD And CEO Effective August 11
Brief: Sun Pharma Advanced Research Says Ocuvex Therapeutics Gets Complete Response Letter For PDP-716 NDA
India's Sun Pharma Advanced Research jumps after swinging to Q4 profit
Brief: Sun Pharma Advanced Research March-Quarter Consol Profit 17.61 Billion Rupees